Free Trial
NYSEARCA:XBI

SPDR S&P Biotech ETF (XBI) Price, Holdings, & News

SPDR S&P Biotech ETF logo
$88.27 +1.25 (+1.44%)
Closing price 04:10 PM Eastern
Extended Trading
$88.14 -0.13 (-0.14%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About SPDR S&P Biotech ETF (NYSEARCA:XBI)

Key Stats

Today's Range
$86.74
$88.55
50-Day Range
$76.37
$88.38
52-Week Range
$66.66
$105.47
Volume
6.41 million shs
Average Volume
9.45 million shs
Market Capitalization
$5.18 billion
Assets Under Management
$5.07 billion
Dividend Yield
0.03%
Net Expense Ratio
0.35%
Aggregate Rating
Moderate Buy

ETF Overview

SPDR S&P Biotech ETF Expenses

TypeXBIHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.35%0.56%0.56%0.51%0.53%
Other Expenses0.00%0.47%0.56%0.59%0.56%
Total Expense0.35%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.35%0.60%0.63%0.58%0.60%
Receive XBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

XBI ETF News Headlines

SPDR S&P Biotech ETF (XBI) - Yahoo Finance
XBI Chart | SPDR S&P Biotech ETF - Investing.com
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
See More Headlines

XBI ETF - Frequently Asked Questions

SPDR S&P Biotech ETF's stock was trading at $90.06 at the beginning of the year. Since then, XBI stock has decreased by 2.0% and is now trading at $88.27.

Top institutional investors of SPDR S&P Biotech ETF include Weatherly Asset Management L. P. (0.27%), Edge Wealth Management LLC (0.19%), Wealth Enhancement Advisory Services LLC (0.17%) and Marotta Asset Management (0.13%).

Shares of XBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Biotech ETF investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and Humana (HUM).

Fund Details

Issuer
SSgA
Fund Name
SPDR S&P Biotech ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:XBI
Inception Date
1/31/2006
Fund Manager
Michael Feehily, Karl Schneider, Raymond Donofrio

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotechnology Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
136

Fund Statistics

Assets Under Management
$5.07 billion
Average Daily Volume
$9.78 million
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
SSgA Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
31,518
Put Options
15,530
Call Options
15,988
Short Interest
18,200 shs

Miscellaneous

Beta
0.97
Creation Unit
50,000
Creation Fee
$250.00
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Top 10 XBI Holdings

XBI Sector Exposure

XBI Industry Exposure


This page (NYSEARCA:XBI) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners